Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.04USD
16 Feb 2018
Change (% chg)

$0.08 (+0.80%)
Prev Close
$9.96
Open
$9.95
Day's High
$10.20
Day's Low
$9.95
Volume
9,541
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.66

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

Beta: --
Market Cap(Mil.): $144.27
Shares Outstanding(Mil.): 14.37
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

Earnings vs. Estimates